By Patrick Wingrove and Yasmeen Abutaleb NEW YORK, Nov 12 (Reuters) – The US Food and Drug Administration has shelved the fast-track drug review initiative launched during the Trump administration by
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)